Diabetes and Endocrinology
Home Diabetes and Endocrinology
Increased Use of Newer Meds for Diabetic Nephropathy in the U.S.
DDP-4 inhibitors used in 54 percent of visits in last quarter of 2014; ACE inhibitors, ARBs often used
Genetic Hyperglycemia Raises Risk of Coronary Artery Disease
Increased risk of coronary artery disease is separate from diabetes risk
Review: Several Classes of Drugs Treat Pain of Diabetic Neuropathy
Longer-term assessments of outcomes needed, researchers say
Paid Malpractice Claims Cut in Half From 1992 to 2014 in U.S.
But, increase in mean compensation amounts and percentage of paid claims exceeding $1 million
Inositol Supplements Don’t Prevent Gestational Diabetes
Findings among women with a family history of diabetes
Many Youths With Diabetes Not Receiving Eye Examinations
Racial minorities less likely to undergo eye exam; increasing net worth increases likelihood of eye exam
CANA/PHEN Aids Weight Loss in Obese Without Type 2 Diabetes
Canagliflozin plus phentermine superior to placebo for weight loss at 26 weeks in obese, overweight
Global Tobacco Control Treaty Has Reduced Smoking Rates
Countries agreed to implement measures such as tobacco taxes and smoke-free public areas
30-Day Mortality Down During Joint Commission Survey Weeks
Patients admitted during survey weeks (versus non-survey weeks) have significantly lower mortality
High BMI in Late Teens Tied to Future Severe Liver Dz in Males
Development of T2DM further increases risk for severe liver disease, regardless of BMI
